[HTML][HTML] Serum proteomic profiling of patients with compensated advanced chronic liver disease with and without clinically significant portal hypertension
F Pastrovic, R Novak, I Grgurevic, S Hrkac, G Salai… - Plos one, 2024 - journals.plos.org
Introduction Portal hypertension (PH) drives the progression of liver cirrhosis to
decompensation and death. Hepatic venous pressure gradient (HVPG) measurement is the …
decompensation and death. Hepatic venous pressure gradient (HVPG) measurement is the …
[HTML][HTML] Serum proteomic profiling of patients with compensated advanced chronic liver disease with and without clinically significant portal hypertension
F Pastrovic, R Novak, I Grgurevic, S Hrkac, G Salai… - PLOS …, 2024 - ncbi.nlm.nih.gov
Materials and methods Consecutive patients with histologically confirmed cACLD and
results of HVPG measurements were prospectively included. Serum samples were pooled …
results of HVPG measurements were prospectively included. Serum samples were pooled …
[PDF][PDF] Serum proteomic profiling of patients with compensated advanced chronic liver disease with and without clinically significant portal hypertension
F Pastrovic, R Novak, I Grgurevic, S Hrkac, G Salai… - PLoS ONE, 2024 - researchgate.net
Portal hypertension (PH) drives the progression of liver cirrhosis to decompensation and
death. Hepatic venous pressure gradient (HVPG) measurement is the standard of PH …
death. Hepatic venous pressure gradient (HVPG) measurement is the standard of PH …
Serum proteomic profiling of patients with compensated advanced chronic liver disease with and without clinically significant portal hypertension
F Pastrovic, R Novak, I Grgurevic, S Hrkac… - PloS …, 2024 - pubmed.ncbi.nlm.nih.gov
Introduction Portal hypertension (PH) drives the progression of liver cirrhosis to
decompensation and death. Hepatic venous pressure gradient (HVPG) measurement is the …
decompensation and death. Hepatic venous pressure gradient (HVPG) measurement is the …
Serum proteomic profiling of patients with compensated advanced chronic liver disease with and without clinically significant portal hypertension.
F Pastrovic, R Novak, I Grgurevic, S Hrkac… - PLoS …, 2024 - search.ebscohost.com
Introduction: Portal hypertension (PH) drives the progression of liver cirrhosis to
decompensation and death. Hepatic venous pressure gradient (HVPG) measurement is the …
decompensation and death. Hepatic venous pressure gradient (HVPG) measurement is the …
Serum proteomic profiling of patients with compensated advanced chronic liver disease with and without clinically significant portal hypertension.
F Pastrovic, R Novak, I Grgurevic, S Hrkac, G Salai… - Plos one, 2024 - europepmc.org
Materials and methods Consecutive patients with histologically confirmed cACLD and
results of HVPG measurements were prospectively included. Serum samples were pooled …
results of HVPG measurements were prospectively included. Serum samples were pooled …